The metal theory of Alzheimer's disease

Advances in Alzheimer's Disease

Volumn 3, Issue , 2012, Pages 277-281

  Bush, Ashley I ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Alzheimer's disease; amyloid; copper; iron; presenilin; tau; zinc

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CERULOPLASMIN; CLIOQUINOL; COPPER; DONEPEZIL; FERROPORTIN; IRON; NOOTROPIC AGENT; PBT 2; PLACEBO; PRESENILIN; TAU PROTEIN; TRANSITION ELEMENT; UNCLASSIFIED DRUG; ZINC;

ALZHEIMER DISEASE; ARTICLE; BIOACCUMULATION; CELL MIGRATION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; HOMEOSTASIS; HUMAN; MOLECULAR PATHOLOGY; NONHUMAN; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

EID: 84877999402     PISSN: 22105727     EISSN: 22105735     Source Type: Book Series    
DOI: 10.3233/978-1-61499-154-0-277     Document Type: Article

References (29)

1. Adlard PA, Parncutt JM, Finkelstein DI, Bush AI (2010) Cognitive loss in zinc transporter-3 knock-out mice: A phenocopy for the synaptic and memory deficits of Alzheimer's disease? J Neurosci 30, 1631-1636
2. Lee J-Y, Cole TB, Palmiter RD, Suh SW, Koh J-Y (2002) Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice. Proc Natl Acad Sci U S A 99, 7705-7710
3. Friedlich AL, Lee JY, van Groen T, Cherny RA, Volitakis I, Cole TB, Palmiter RD,Koh JY, Bush AI (2004) Neuronal zinc exchange with the blood vessel wall promotes cerebral amyloid angiopathy in an animal model of Alzheimer's disease. J Neurosci 24, 3453-3459
4. Miller LM,Wang Q, Telivala TP, Smith RJ, Lanzirotti A, Miklossy J (2006) Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with beta-Amyloid deposits in Alzheimer's disease. J Struct Biol 155, 30-37
5. Lovell MA, Robertson JD, Teesdale WJ, Campbell JL, Markesbery WR (1998) Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci 158, 47-52
6. Sensi SL, Paoletti P, Koh JY, Aizenman E, Bush AI, Hershfinkel M (2011) The neurophysiology and pathology of brain zinc. J Neurosci 31, 16076-16085
7. Bush AI, Pettingell WH, Multhaup G, Paradis Md, Vonsattel JP, Gusella JF, Beyreuther K, Masters CL, Tanzi RE (1994) Rapid induction of Alzheimer A amyloid formation by zinc. Science 265, 1464-1467
8. Miller Y, Ma B, Nussinov R (2010) Zinc ions promote Alzheimer Abeta aggregation via population shift of polymorphic states. Proc Natl Acad Sci U S A 107, 9490-9495
9. Adlard PA, Bica L, White AR, Nurjono M, Filiz G, Crouch PJ, Donnelly PS, Cappai R, Finkelstein DI, Bush AI (2011) Metal ionophore treatment restores dendritic spine density and synaptic protein levels in a mouse model of Alzheimer's disease. PLoS ONE 6, e17669
10. Cherny RA, Atwood CS, Xilinas ME, Gray DN, Jones WD, McLean CA, Barnham KJ, Volitakis I, Fraser FW, Kim Y, Huang X, Goldstein LE, Moir RD, Lim JT, Beyreuther K, Zheng H,Tanzi RE, Masters CL, Bush AI (2001)Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-Amyloid accumulation in Alzheimer's disease transgenic mice. Neuron 30, 665-676
11. Adlard PA, Cherny RA, Finkelstein DI, Gautier E, Robb E, Cortes M, Volitakis I, Liu X, Smith JP, Perez K, Laughton K, Li QX, Charman SA, Nicolazzo JA, Wilkins S, Deleva K, Lynch T, Kok G, Ritchie CW, Tanzi RE, Cappai R, Masters CL, Barnham KJ, Bush AI (2008) Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta. Neuron 59, 43-55
12. Lannfelt L, Blennow K, Zetterberg H, Batsman S, Ames D, Harrison J, Masters CL, Targum S, Bush AI, Murdoch R, Wilson J, Ritchie CW (2008) Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: A phase IIa, double-blind, randomised, placebo-controlled trial. Lancet Neurol 7, 779-786
13. Lannfelt L, Blennow K, Zetterberg H, Batsman S, Ames D, Harrison J, Masters CL, Targum S, Bush AI, Murdoch R, Wilson J, Ritchie CW (2009) Erratum: Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as amodifying therapy for Alzheimer's disease: A Phase IIa, double-blind, randomised, placebo-controlled trial. Lancet Neurol 8, 981
14. Faux NG, Ritchie CW, Gunn A, Rembach A, Tsatsanis A, Bedo J, Harrison J, Lannfelt L, Blennow K, Zetterberg H, Ingelsson M, Masters CL, Tanzi RE, Cummings JL, Herd CM, Bush AI (2010) PBT2 rapidly improves cognition in Alzheimer's Disease: Additional phase II analyses. J Alzheimers Dis 20, 509-516
15. Rogers SL, Farlow MR, Doody RS, Mohs R, Friedhoff LT (1998) A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group. Neurology 50, 136-145
16. Crouch PJ, Savva MS, Hung LW, Donnelly PS, Mot AI, Parker SJ, Greenough MA, Volitakis I, Adlard PA, Cherny RA, Masters CL, Bush AI, Barnham KJ, White AR (2011) The Alzheimer's therapeutic PBT2 promotes amyloid-beta degradation andGSK3phosphorylation via a metal chaperone activity. J Neurochem 119, 220-230
17. Duce JA, Tsatsanis A, Cater MA, James SA, Robb E, Wikhe K, Leong SL, Perez K, Johanssen T, Greenough MA, Cho HH, Galatis D, Moir RD, Masters CL, McLean C, Tanzi RE, Cappai R, Barnham KJ, Ciccotosto GD, Rogers JT, Bush AI (2010) Iron-export ferroxidase activity of beta-Amyloid precursor protein is inhibited by zinc in Alzheimer's disease. Cell 142, 857-867
18. Lei P, Ayton S, Finkelstein DI, Spoerri L, Ciccotosto GD, Wright DK, Wong BXW, Adlard PA, Cherny RA, Lam LQ, Roberts BR, Volitakis I, Egan GF, McLean CA, Cappai R, Duce JA, Bush AI (2012) Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export. Nat Med 18, 291-295
19. Ninomiya H, Roch JM, Sundsmo MP, Otero DAC, Saitoh T (1993) Amino acid sequence RERMS represents the active domain of amyloid -/A4 protein precursor that promotes fibroblast growth. J Cell Biol 121, 879-886
20. Smith MA, Harris PLR, Sayre LM, Perry G (1997) Iron accumulation in Alzheimer's disease is a source of redoxgenerated free radicals. Proc Natl Acad Sci U S A 94, 9866-9868
21. Sayre LM, Perry G, Harris PL, LiuY, Schubert KA, SmithMA (2000) In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: A central role for bound transition metals. J Neurochem 74, 270-279
22. Tardiff DF, Tucci ML, Caldwell KA, Caldwell GA, Lindquist S (2012) Different 8-hydroxyquinolines protect models of TDP-43, alpha-synuclein, and polyglutamine proteotoxicity through distinct mechanisms. J Biol Chem 287, 4107-4120
23. Duce JA, Ayton S, Miller AA, Tsatsanis A, Lam LQ, Leone L, Corbin JE, Butzkueven H, Kilpatrick TJ, Rogers JT, Barnham KJ, Finkelstein DI, Bush AI (2012) Amine oxidase activity of-Amyloid precursor protein modulates systemic and local catecholamine levels. Mol Psychiatry, doi: 10.1038/mp.2011.168
24. Greenough MA, Volitakis I, Li QX, Laughton K, Evin G, Ho M, Dalziel AH, Camakaris J, Bush AI (2011) Presenilins promote the cellular uptake of copper and zinc and maintain Cu-chaperone of sod1-dependent Cu/Zn superoxide dismutase activity. J Biol Chem 286, 9776-9786
25. Zhang C,Wu B, Beglopoulos V,Wines-Samuelson M, Zhang D, Dragatsis I, Sudhof TC, Shen J (2009) Presenilins are essential for regulating neurotransmitter release. Nature 460, 632-636
26. Dingwall C (2007) A copper-binding site in the cytoplasmic domain of BACE1 identifies a possible link to metal homoeostasis and oxidative stress in Alzheimer's disease. Biochem Soc Trans 35, 571-573
27. Cater MA, McInnes KT, Li QX, Volitakis I, La Fontaine S, Mercer JF, Bush AI (2008) Intracellular copper deficiency increases amyloid-beta secretion by diverse mechanisms. Biochem J 412, 141-152
28. Hung YH, Robb EL, Volitakis I, Ho M, Evin G, Li QX, Culvenor JG, Masters CL, Cherny RA, Bush AI (2009) Paradoxical condensation of copper with elevated beta-Amyloid in lipid rafts under cellular copper deficiency conditions: Implications for Alzheimer disease. J Biol Chem 284, 21899-21907
29. James SA, Volitakis I, Adlard PA, Duce JA, Masters CL, Cherny RA, Bush AI (2012) Elevated labile Cu is associated with oxidative pathology in Alzheimer disease. Free Radic Biol Med 52, 298-302